関連する実験動画
Updated: Sep 10, 2025
06:21
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
8.8K
泌尿器がんにおけるmRNAワクチンの進歩
You-Min Shen1, Fang-Ning Wan1, Hua Xu1
1Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Shanghai Genitourinary Cancer Institute, Shanghai 200032, China.
Biochimica et biophysica acta. Reviews on cancer
|August 22, 2025
まとめ
メッセンジャーRNA (mRNA) 技術は 癌治療に革命を起こし 個別化されたワクチンや治療法を提供しています このレビューでは,mRNA
科学分野:
- 腫瘍学と免疫学
- バイオテクノロジーと遺伝子工学
背景:
- メッセンジャーRNA (mRNA) 技術は急速に進歩し,コストが低下し,医療介入での使用が増加しています.
- 伝統的な方法とは異なり,mRNAワクチンは次世代のシーケンシング (NGS) を活用して個別化された設計を行っています.
- mRNA技術は,抗原エンコーディング,サイトカイン配送,遺伝子治療,T細胞ベースの治療を含む,癌の治療に多岐にわたる応用を提供します.
研究 の 目的:
- 性泌尿器がんにおけるmRNAワクチンの開発と適用をレビューする.
- 多様な合成mRNA型と効率的な配送システムを要約する.
- mRNAベースのがん治療における臨床前および臨床調査,課題,および将来の機会について議論する.
主な方法:
- 性泌尿器がんにおけるmRNAワクチンに関する臨床前および臨床研究の文献レビュー.
- 合成mRNAのタイプ,配送システム,治療戦略の分析
- この分野における現在の障害と将来の展望の検討
主要な成果:
- mRNAベースのアプローチは,臨床前がん研究において有望であり,いくつかは臨床試験に進んでいます.
- 承認されたmRNAワクチンの安全性と有効性は,mRNA療法に対する関心が高まっていることを支持しています.
- mRNA技術は 癌治療の将来において 重要な役割を果たすでしょう
結論:
- mRNA技術は,特に泌尿器がんの新型がん治療の開発に強力なプラットフォームを提供します.
- 多様なmRNA型,配送システム,臨床応用に関する継続的な研究は不可欠です.
- 現在の障害を克服することで,mRNAベースの治療法が患者の治療結果を 完全に発揮できるようになるでしょう.
関連する概念動画
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
01:29Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
01:03Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
01:51Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
02:33Initiation of Translation
34.5K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
34.5K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K